A Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population
Pomfret, Thomas C.
Greenwood, Bonnie C.
Trask, Nicole M.
Schiff, Nancy L.
Price, Mylissa K.
Alper, Caroline J.
Lenz, Kimberly J.
Jeffrey, Paul L.
UMass Chan AffiliationsCommonwealth Medicine, Office of Clinical Affairs/MassHealth
Commonwealth Medicine, Clinical Pharmacy Services
Commonwealth Medicine, Center for Health Policy and Research
Drug Utilization Review
Health Services Administration
Health Services Research
Pharmacoeconomics and Pharmaceutical Economics
MetadataShow full item record
AbstractThis poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017. This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the AMCP Foundation Best Poster Award in the Resident and Fellows category.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/26958
Rights© 2018 University of Massachusetts Medical School